Advances in the Study of Immunosuppressive Mechanisms in Sepsis

References

• Bauer M, Gerlach H, Vogelmann T, et al. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis. Crit Care. 2020;24(1):239. doi:10.1186/s13054-020-02950-2
   PubMed Web of Science ®Google Scholar
• Rhee C, Klompas M. Sepsis trends: increasing incidence and decreasing mortality, or changing denominator? J Thorac Dis. 2020;12(Suppl 1):S89. doi:10.21037/jtd.2019.12.51
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
   PubMed Web of Science ®Google Scholar
• Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management. BMJ. 2016;353:i1585. doi:10.1136/bmj.i1585
   PubMed Web of Science ®Google Scholar
• Cecconi M, Evans L, Levy M, et al. Sepsis and septic shock. Lancet. 2018;392(10141):75–87. doi:10.1016/S0140-6736(18)30696-2
   PubMed Web of Science ®Google Scholar
• Liu D, Huang S-Y, Sun J-H, et al. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options. Mil Med Res. 2022;9(1):56. doi:10.1186/s40779-022-00422-y
   PubMed Web of Science ®Google Scholar
• Boyd JH. Toll-like receptors and opportunities for new sepsis therapeutics. Curr Infect Dis Rep. 2012;14(5):455–461. doi:10.1007/s11908-012-0273-5
   PubMed Web of Science ®Google Scholar
• Vincent JL. Current sepsis therapeutics. EBioMedicine. 2022;86:104318. doi:10.1016/j.ebiom.2022.104318
   PubMed Web of Science ®Google Scholar
• Esposito S, De Simone G, Boccia G, et al. Sepsis and septic shock: new definitions, new diagnostic and therapeutic approaches. J Glob Antimicrob Resist. 2017;10:204–212. doi:10.1016/j.jgar.2017.06.013
   PubMed Web of Science ®Google Scholar
• Denning NL, Aziz M, Gurien SD, et al. DAMPs and NETs in sepsis. Front Immunol. 2019;10:2536. doi:10.3389/fimmu.2019.02536
   PubMed Web of Science ®Google Scholar
• Joffre J, Hellman J, Ince C, et al. Endothelial responses in sepsis. Am J Respir Crit Care Med. 2020;202(3):361–370. doi:10.1164/rccm.201910-1911TR
   PubMed Web of Science ®Google Scholar
• Kumar V. Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets. Int Immunopharmacol. 2020;89(Pt B):107087. doi:10.1016/j.intimp.2020.107087
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140(6):805–820. doi:10.1016/j.cell.2010.01.022
   PubMed Web of Science ®Google Scholar
• Chousterman BG, Swirski FK, Weber GF. Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol. 2017;39(5):517–528. doi:10.1007/s00281-017-0639-8
   PubMed Web of Science ®Google Scholar
• Frimpong A, Owusu EDA, Amponsah JA, et al. Cytokines as potential biomarkers for differential diagnosis of sepsis and other non-septic disease conditions. Front Cell Infect Microbiol. 2022;12:901433. doi:10.3389/fcimb.2022.901433
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis. 2013;13(3):260–268. doi:10.1016/S1473-3099(13)70001-X
   PubMed Web of Science ®Google Scholar
• Chan JK, Roth J, Oppenheim JJ, et al. Alarmins: awaiting a clinical response. J Clin Invest. 2012;122(8):2711–2719. doi:10.1172/JCI62423
   PubMed Web of Science ®Google Scholar
• Deutschman CS, Tracey KJ. Sepsis: current dogma and new perspectives. Immunity. 2014;40(4):463–475. doi:10.1016/j.immuni.2014.04.001
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Schmieg RE, Swanson PE, et al. Rapid onset of intestinal epithelial and lymphocyte apoptotic cell death in patients with trauma and shock. Crit Care Med. 2000;28(9):3207–3217. doi:10.1097/00003246-200009000-00016
   PubMed Web of Science ®Google Scholar
• Zhang Z, Huang S, Wu S, et al. Clearance of apoptotic cells by mesenchymal stem cells contributes to immunosuppression via PGE2. EBioMedicine. 2019;45:341–350. doi:10.1016/j.ebiom.2019.06.016
   PubMed Web of Science ®Google Scholar
• Xu J, Li J, Xiao K, et al. Dynamic changes in human HLA-DRA gene expression and Th cell subsets in sepsis: indications of immunosuppression and associated outcomes. Scand J Immunol. 2020;91(1):e12813. doi:10.1111/sji.12813
   PubMed Web of Science ®Google Scholar
• Cabrera-Perez J, Condotta SA, Badovinac VP, et al. Impact of sepsis on CD4 T cell immunity. J Leukoc Biol. 2014;96(5):767–777. doi:10.1189/jlb.5MR0114-067R
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13(12):862–874. doi:10.1038/nri3552
   PubMed Web of Science ®Google Scholar
• Boomer JS, To K, Chang KC, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011;306(23):2594–2605. doi:10.1001/jama.2011.1829
   PubMed Web of Science ®Google Scholar
• Grailer JJ, Kalbitz M, Zetoune FS, et al. Persistent neutrophil dysfunction and suppression of acute lung injury in mice following cecal ligation and puncture sepsis. J Innate Immun. 2014;6(5):695–705. doi:10.1159/000362554
   PubMed Web of Science ®Google Scholar
• Jia SH, Parodo J, Charbonney E, et al. Activated neutrophils induce epithelial cell apoptosis through oxidant-dependent tyrosine dephosphorylation of caspase-8. Am J Pathol. 2014;184(4):1030–1040. doi:10.1016/j.ajpath.2013.12.031
   PubMed Web of Science ®Google Scholar
• Sloan-Lancaster J, Evavold BD, Allen PM. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature. 1993;363(6425):156–159. doi:10.1038/363156a0
   PubMed Web of Science ®Google Scholar
• Lechler R, Chai J-G, Marelli-Berg F, et al. T-cell anergy and peripheral T-cell tolerance. Philos Trans R Soc Lond B Biol Sci. 2001;356(1409):625–637. doi:10.1098/rstb.2001.0844
   PubMed Web of Science ®Google Scholar
• Jenkins MK, Schwartz RH. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med. 1987;165(2):302–319. doi:10.1084/jem.165.2.302
   PubMed Web of Science ®Google Scholar
• Schwartz RH. T cell anergy. Annu Rev Immunol. 2003;21:305–334. doi:10.1146/annurev.immunol.21.120601.141110
   PubMed Web of Science ®Google Scholar
• Ledo C, Gonzalez CD, Poncini CV, et al. TNFR1 signaling contributes to T cell anergy during staphylococcus aureus sepsis. Front Cell Infect Microbiol. 2018;8:259. doi:10.3389/fcimb.2018.00259
   PubMed Web of Science ®Google Scholar
• Huang S, Liu D, Sun J, et al. Tim-3 regulates sepsis-induced immunosuppression by inhibiting the NF-kappaB signaling pathway in CD4 T cells. Mol Ther. 2022;30(3):1227–1238. doi:10.1016/j.ymthe.2021.12.013
   PubMed Web of Science ®Google Scholar
• Gao Y, Wang C, Wang Z, et al. Semaphorin 3A contributes to sepsis‑induced immunosuppression by impairing CD4 + T cell anergy. Mol Med Rep. 2021;23(4). doi:10.3892/mmr.2021.11941
   Web of Science ®Google Scholar
• Cambier JC, Gauld SB, Merrell KT, et al. B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nat Rev Immunol. 2007;7(8):633–643. doi:10.1038/nri2133
   PubMed Web of Science ®Google Scholar
• Cambier JC, Getahun A. B cell activation versus anergy; the antigen receptor as a molecular switch. Immunol Lett. 2010;128(1):6–7. doi:10.1016/j.imlet.2009.09.006
   PubMed Web of Science ®Google Scholar
• Vidard L, Dureuil C, Baudhuin J, et al. CD137(4-1BB) engagement fine-tunes synergistic IL-15- and IL-21-Driven NK cell proliferation. J Immunol. 2019;203(3):676–685. doi:10.4049/jimmunol.1801137
   PubMed Web of Science ®Google Scholar
• Tseng HC, Cacalano N, Jewett A. Split anergized Natural Killer cells halt inflammation by inducing stem cell differentiation, resistance to NK cell cytotoxicity and prevention of cytokine and chemokine secretion. Oncotarget. 2015;6(11):8947–8959. doi:10.18632/oncotarget.3250
   PubMedGoogle Scholar
• Taneja R, Parodo J, Jia SH, et al. Delayed neutrophil apoptosis in sepsis is associated with maintenance of mitochondrial transmembrane potential and reduced caspase-9 activity. Crit Care Med. 2004;32(7):1460–1469. doi:10.1097/01.CCM.0000129975.26905.77
   PubMed Web of Science ®Google Scholar
• Fialkow L, Fochesatto Filho L, Bozzetti MC, et al. Neutrophil apoptosis: a marker of disease severity in sepsis and sepsis-induced acute respiratory distress syndrome. Crit Care. 2006;10(6):R155. doi:10.1186/cc5090
   PubMed Web of Science ®Google Scholar
• Harrell CR, Volarevic V. Apoptosis: a friend or foe in mesenchymal stem cell-based immunosuppression. Adv Protein Chem Struct Biol. 2021;126:39–62.
   PubMed Web of Science ®Google Scholar
• Cao C, Yu M, Chai Y. Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis. Cell Death Dis. 2019;10(10):782. doi:10.1038/s41419-019-2015-1
   PubMedGoogle Scholar
• Su L, Pan P, Yan P, et al. Role of vimentin in modulating immune cell apoptosis and inflammatory responses in sepsis. Sci Rep. 2019;9(1):5747. doi:10.1038/s41598-019-42287-7
   PubMed Web of Science ®Google Scholar
• Gao K, Jin J, Huang C, et al. Exosomes derived from septic mouse serum modulate immune responses via exosome-associated cytokines. Front Immunol. 2019;10:1560. doi:10.3389/fimmu.2019.01560
   PubMed Web of Science ®Google Scholar
• Oberholzer A, Oberholzer C, Moldawer LL. Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med. 2002;30(1 Supp):S58–S63. doi:10.1097/00003246-200201001-00008
   Web of Science ®Google Scholar
• Nascimento DC, Melo PH, Piñeros AR, et al. IL-33 contributes to sepsis-induced long-term immunosuppression by expanding the regulatory T cell population. Nat Commun. 2017;8:14919. doi:10.1038/ncomms14919
   PubMed Web of Science ®Google Scholar
• Ge Y, Huang M, Wu Y, et al. Interleukin-38 protects against sepsis by augmenting immunosuppressive activity of CD4 + CD25 + regulatory T cells. J Cell Mol Med. 2020;24(2):2027–2039. doi:10.1111/jcmm.14902
   PubMed Web of Science ®Google Scholar
• Wang YC, Weng G-P, Liu J-P, et al. Elevated serum IL-37 concentrations in patients with sepsis. Medicine. 2019;98(10):e14756. doi:10.1097/MD.0000000000014756
   PubMed Web of Science ®Google Scholar
• Ge Y, Huang M, Yao YM. Recent advances in the biology of IL-1 family cytokines and their potential roles in development of sepsis. Cytokine Growth Factor Rev. 2019;45:24–34. doi:10.1016/j.cytogfr.2018.12.004
   PubMed Web of Science ®Google Scholar
• Su Y, Qu Y, Zhao F, et al. Regulation of autophagy by the nuclear factor kappaB signaling pathway in the hippocampus of rats with sepsis. J Neuroinflammation. 2015;12:116. doi:10.1186/s12974-015-0336-2
   PubMed Web of Science ®Google Scholar
• Cadwell K. Crosstalk between autophagy and inflammatory signalling pathways: balancing defence and homeostasis. Nat Rev Immunol. 2016;16(11):661–675.
   PubMed Web of Science ®Google Scholar
• Levine B. Eating oneself and uninvited guests: autophagy-related pathways in cellular defense. Cell. 2005;120(2):159–162. doi:10.1016/j.cell.2005.01.005
   PubMed Web of Science ®Google Scholar
• Hsieh CH, Pai P-Y, Hsueh H-W, et al. Complete induction of autophagy is essential for cardioprotection in sepsis. Ann Surg. 2011;253(6):1190–1200. doi:10.1097/SLA.0b013e318214b67e
   PubMed Web of Science ®Google Scholar
• Lin CW, Lo S, Hsu C, et al. T-cell autophagy deficiency increases mortality and suppresses immune responses after sepsis. PLoS One. 2014;9(7):e102066. doi:10.1371/journal.pone.0102066
   PubMed Web of Science ®Google Scholar
• Wang Z, Li Y, Yang X, et al. Protective effects of rapamycin induced autophagy on CLP septic mice. Comp Immunol Microbiol Infect Dis. 2019;64:47–52. doi:10.1016/j.cimid.2019.01.009
   PubMed Web of Science ®Google Scholar
• Yin X, Xin H, Mao S, et al. The role of autophagy in sepsis: protection and injury to organs. Front Physiol. 2019;10:1071. doi:10.3389/fphys.2019.01071
   PubMed Web of Science ®Google Scholar
• Shang S, Wu J, Li X, et al. Artesunate interacts with the vitamin D receptor to reverse sepsis-induced immunosuppression in a mouse model via enhancing autophagy. Br J Pharmacol. 2020;177(18):4147–4165. doi:10.1111/bph.15158
   PubMed Web of Science ®Google Scholar
• Unuma K, Aki T, Funakoshi T, et al. Extrusion of mitochondrial contents from lipopolysaccharide-stimulated cells: involvement of autophagy. Autophagy. 2015;11(9):1520–1536. doi:10.1080/15548627.2015.1063765
   PubMed Web of Science ®Google Scholar
• Venet F, Monneret G. Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol. 2018;14(2):121–137. doi:10.1038/nrneph.2017.165
   PubMed Web of Science ®Google Scholar
• Liu D, Cao S, Zhou Y, et al. Recent advances in endotoxin tolerance. J Cell Biochem. 2019;120(1):56–70. doi:10.1002/jcb.27547
   PubMed Web of Science ®Google Scholar
• Shalova IN, Lim J, Chittezhath M, et al. Human monocytes undergo functional re-programming during sepsis mediated by hypoxia-inducible factor-1alpha. Immunity. 2015;42(3):484–498. doi:10.1016/j.immuni.2015.02.001
   PubMed Web of Science ®Google Scholar
• Allantaz-Frager F, Turrel-Davin F, Venet F, et al. Identification of biomarkers of response to IFNg during endotoxin tolerance: application to septic shock. PLoS One. 2013;8(7):e68218. doi:10.1371/journal.pone.0068218
   PubMed Web of Science ®Google Scholar
• Mukherjee R, Tompkins CA, Ostberg NP, et al. Drp1/Fis1-dependent pathologic fission and associated damaged extracellular mitochondria contribute to macrophage dysfunction in endotoxin tolerance. Crit Care Med. 2022;50(6):e504–e515. doi:10.1097/CCM.0000000000005437
   PubMed Web of Science ®Google Scholar
• Sternberg EM. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol. 2006;6(4):318–328. doi:10.1038/nri1810
   PubMed Web of Science ®Google Scholar
• Chavan SS, Tracey KJ. Essential neuroscience in immunology. J Immunol. 2017;198(9):3389–3397. doi:10.4049/jimmunol.1601613
   PubMed Web of Science ®Google Scholar
• Joffre J, Wong E, Lawton S, et al. N-Oleoyl dopamine induces IL-10 via central nervous system TRPV1 and improves endotoxemia and sepsis outcomes. J Neuroinflammation. 2022;19(1):118. doi:10.1186/s12974-022-02485-z
   PubMed Web of Science ®Google Scholar
• Ren C, Yao R-Q, Zhang H, et al. Sepsis-associated encephalopathy: a vicious cycle of immunosuppression. J Neuroinflammation. 2020;17(1):14. doi:10.1186/s12974-020-1701-3
   PubMed Web of Science ®Google Scholar
• Lin J, Tan B, Li Y, et al. Sepsis-exacerbated brain dysfunction after intracerebral hemorrhage. Front Cell Neurosci. 2021;15:819182. doi:10.3389/fncel.2021.819182
   PubMed Web of Science ®Google Scholar
• Carson WF, Cavassani KA, Dou Y, et al. Epigenetic regulation of immune cell functions during post-septic immunosuppression. Epigenetics. 2011;6(3):273–283. doi:10.4161/epi.6.3.14017
   PubMed Web of Science ®Google Scholar
• Binnie A, Tsang JLY, Hu P, et al. Epigenetics of Sepsis. Crit Care Med. 2020;48(5):745–756. doi:10.1097/CCM.0000000000004247
   PubMed Web of Science ®Google Scholar
• Takebe M, Oishi H, Taguchi K, et al. Inhibition of histone deacetylases protects septic mice from lung and splenic apoptosis. J Surg Res. 2014;187(2):559–570. doi:10.1016/j.jss.2013.10.050
   PubMed Web of Science ®Google Scholar
• Roquilly A, Jacqueline C, Davieau M, et al. Alveolar macrophages are epigenetically altered after inflammation, leading to long-term lung immunoparalysis. Nat Immunol. 2020;21(6):636–648. doi:10.1038/s41590-020-0673-x
   PubMed Web of Science ®Google Scholar
• Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature. 2007;447(7143):425–432. doi:10.1038/nature05918
   PubMed Web of Science ®Google Scholar
• Chan C, Li L, McCall CE, et al. Endotoxin tolerance disrupts chromatin remodeling and NF-kappaB transactivation at the IL-1beta promoter. J Immunol. 2005;175(1):461–468. doi:10.4049/jimmunol.175.1.461
   PubMed Web of Science ®Google Scholar
• El GM, Yoza BK, Chen X, et al. Chromatin-specific remodeling by HMGB1 and linker histone H1 silences proinflammatory genes during endotoxin tolerance. Mol Cell Biol. 2009;29(7):1959–1971. doi:10.1128/MCB.01862-08
   PubMed Web of Science ®Google Scholar
• Lorente-Sorolla C, Garcia-Gomez A, Català-Moll F, et al. Inflammatory cytokines and organ dysfunction associate with the aberrant DNA methylome of monocytes in sepsis. Genome Med. 2019;11(1):66. doi:10.1186/s13073-019-0674-2
   PubMed Web of Science ®Google Scholar
• Davis FM, Schaller MA, Dendekker A, et al. Sepsis induces prolonged epigenetic modifications in bone marrow and peripheral macrophages impairing inflammation and wound healing. Arterioscler Thromb Vasc Biol. 2019;39(11):2353–2366. doi:10.1161/ATVBAHA.119.312754
   PubMed Web of Science ®Google Scholar
• O’Connell RM, Rao DS, Chaudhuri AA, et al. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol. 2010;10(2):111–122. doi:10.1038/nri2708
   PubMed Web of Science ®Google Scholar
• Wang JF, Yu M-L, Yu G, et al. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem Biophys Res Commun. 2010;394(1):184–188. doi:10.1016/j.bbrc.2010.02.145
   PubMed Web of Science ®Google Scholar
• El GM, Church A, Liu T, et al. MicroRNA-146a regulates both transcription silencing and translation disruption of TNF-alpha during TLR4-induced gene reprogramming. J Leukoc Biol. 2011;90(3):509–519. doi:10.1189/jlb.0211074
   PubMed Web of Science ®Google Scholar
• El GM, McCall CE. MicroRNAs distinguish translational from transcriptional silencing during endotoxin tolerance. J Biol Chem. 2010;285(27):20940–20951. doi:10.1074/jbc.M110.115063
   PubMed Web of Science ®Google Scholar
• Ibanez-Cabellos JS, Aguado C, Pérez-Cremades D, et al. Extracellular histones activate autophagy and apoptosis via mTOR signaling in human endothelial cells. Biochim Biophys Acta Mol Basis Dis. 2018;1864(10):3234–3246. doi:10.1016/j.bbadis.2018.07.010
   PubMed Web of Science ®Google Scholar
• Carson WT, Kunkel SL. Regulation of cellular immune responses in sepsis by histone modifications. Adv Protein Chem Struct Biol. 2017;106:191–225.
   PubMed Web of Science ®Google Scholar
• Bomsztyk K, Mar D, An D, et al. Experimental acute lung injury induces multi-organ epigenetic modifications in key angiogenic genes implicated in sepsis-associated endothelial dysfunction. Crit Care. 2015;19(1):225. doi:10.1186/s13054-015-0943-4
   PubMedGoogle Scholar
• Li Y, Liu Z, Liu B, et al. Citrullinated histone H3: a novel target for the treatment of sepsis. Surgery. 2014;156(2):229–234. doi:10.1016/j.surg.2014.04.009
   PubMed Web of Science ®Google Scholar
• Shen MJ, Sun L-C, Liu X-Y, et al. Trichostatin A improves the inflammatory response and liver injury in septic mice through the FoxO3a/autophagy signaling pathway. World J Emerg Med. 2022;13(3):182–188. doi:10.5847/wjem.j.1920-8642.2022.056
   PubMed Web of Science ®Google Scholar
• Zhao T, Alam HB, Liu B, et al. Selective inhibition of SIRT2 improves outcomes in a lethal septic model. Curr Mol Med. 2015;15(7):634–641. doi:10.2174/156652401507150903185852
   PubMed Web of Science ®Google Scholar
• Zhao T, Li Y, Bronson RT, et al. Selective histone deacetylase-6 inhibition attenuates stress responses and prevents immune organ atrophy in a lethal septic model. Surgery. 2014;156(2):235–242. doi:10.1016/j.surg.2014.03.033
   PubMed Web of Science ®Google Scholar
• Williams AM, Dennahy IS, Bhatti UF, et al. Histone deacetylase inhibitors: a novel strategy in trauma and sepsis. Shock. 2019;52(3):300–306. doi:10.1097/SHK.0000000000001308
   PubMed Web of Science ®Google Scholar
• Yong H, Wu G, Chen J, et al. lncRNA MALAT1 accelerates skeletal muscle cell apoptosis and inflammatory response in sepsis by decreasing BRCA1 expression by recruiting EZH2. Mol Ther Nucleic Acids. 2020;19:97–108. doi:10.1016/j.omtn.2019.10.028
   PubMedGoogle Scholar
• Zhao D, Li Z, Liu X, et al. Lymphocyte expression of EZH2 is associated with mortality and secondary infectious complications in sepsis. Int Immunopharmacol. 2020;89(Pt B):107042. doi:10.1016/j.intimp.2020.107042
   PubMedGoogle Scholar
• Yue D, Wang Z, Yang Y, et al. EZH2 inhibitor GSK343 inhibits sepsis-induced intestinal disorders. Exp Ther Med. 2021;21(5):437. doi:10.3892/etm.2021.9854
   PubMed Web of Science ®Google Scholar
• Pan Y, Wang J, Xue Y, et al. GSKJ4 protects mice against early sepsis via reducing proinflammatory factors and up-regulating MiR-146a. Front Immunol. 2018;9:2272. doi:10.3389/fimmu.2018.02272
   PubMed Web of Science ®Google Scholar
• Cheng SC, Scicluna BP, Arts RJW, et al. Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis. Nat Immunol. 2016;17(4):406–413. doi:10.1038/ni.3398
   PubMed Web of Science ®Google Scholar
• O’Neill LA, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016;16(9):553–565. doi:10.1038/nri.2016.70
   PubMed Web of Science ®Google Scholar
• Stienstra R, Netea-Maier RT, Riksen NP, et al. Specific and complex reprogramming of cellular metabolism in myeloid cells during innate immune responses. Cell Metab. 2017;26(1):142–156. doi:10.1016/j.cmet.2017.06.001
   PubMed Web of Science ®Google Scholar
• Zhang B, Moorlag SJCFM, Dominguez-Andres J, et al. Single-cell RNA sequencing reveals induction of distinct trained-immunity programs in human monocytes. J Clin Invest. 2022;132(7). doi:10.1172/JCI147719
   Web of Science ®Google Scholar
• Gandhirajan A, Roychowdhury S, Vachharajani V. Sirtuins and sepsis: cross talk between redox and epigenetic pathways. Antioxidants. 2021;11(1):3. doi:10.3390/antiox11010003
   Web of Science ®Google Scholar
• Liu TF, Vachharajani V, Millet P, et al. Sequential actions of SIRT1-RELB-SIRT3 coordinate nuclear-mitochondrial communication during immunometabolic adaptation to acute inflammation and sepsis. J Biol Chem. 2015;290(1):396–408. doi:10.1074/jbc.M114.566349
   PubMed Web of Science ®Google Scholar
• Martin AN, Alexander-Miller M, Yoza BK, et al. Sirtuin1 targeting reverses innate and adaptive immune tolerance in septic mice. J Immunol Res. 2018;2018:2402593. doi:10.1155/2018/2402593
   PubMed Web of Science ®Google Scholar
• Wang X, Wang Z, Tang D. Aerobic exercise improves LPS-induced sepsis via regulating the Warburg effect in mice. Sci Rep. 2021;11(1):1–12. doi:10.1038/s41598-020-79139-8
   PubMed Web of Science ®Google Scholar
• Dominguez-Andres J, Novakovic B, Li Y, et al. The itaconate pathway is a central regulatory node linking innate immune tolerance and trained immunity. Cell Metab. 2019;29(1):211–220.e5. doi:10.1016/j.cmet.2018.09.003
   PubMed Web of Science ®Google Scholar
• Novakovic B, Habibi E, Wang S-Y, et al. β-glucan reverses the epigenetic state of LPS-induced immunological tolerance. Cell. 2016;167(5):1354–1368.e14. doi:10.1016/j.cell.2016.09.034
   PubMed Web of Science ®Google Scholar
• Kaufmann I, Hoelzl A, Schliephake F, et al. Polymorphonuclear leukocyte dysfunction syndrome in patients with increasing sepsis severity. Shock. 2006;26(3):254–261. doi:10.1097/01.shk.0000223131.64512.7a
   PubMed Web of Science ®Google Scholar
• Dimoula A, Pradier O, Kassengera Z, et al. Serial determinations of neutrophil CD64 expression for the diagnosis and monitoring of sepsis in critically ill patients. Clin Infect Dis. 2014;58(6):820–829. doi:10.1093/cid/cit936
   PubMed Web of Science ®Google Scholar
• Conway MA, Datta D, Shankar-Hari M, et al. Cell-surface signatures of immune dysfunction risk-stratify critically ill patients: INFECT study. Intensive Care Med. 2018;44(5):627–635. doi:10.1007/s00134-018-5247-0
   PubMed Web of Science ®Google Scholar
• Winkler MS, Rissiek A, Priefler M, et al. Human leucocyte antigen (HLA-DR) gene expression is reduced in sepsis and correlates with impaired TNFalpha response: a diagnostic tool for immunosuppression? PLoS One. 2017;12(8):e0182427. doi:10.1371/journal.pone.0182427
   PubMed Web of Science ®Google Scholar
• Yin J, Chen Y, Huang J-L, et al. Prognosis-related classification and dynamic monitoring of immune status in patients with sepsis: a prospective observational study. World J Emerg Med. 2021;12(3):185–191. doi:10.5847/wjem.j.1920-8642.2021.03.004
   PubMed Web of Science ®Google Scholar
• Peronnet E, Venet F, Maucort-Boulch D, et al. Association between mRNA expression of CD74 and IL10 and risk of ICU-acquired infections: a multicenter cohort study. Intensive Care Med. 2017;43(7):1013–1020. doi:10.1007/s00134-017-4805-1
   PubMed Web of Science ®Google Scholar
• Polilli E, Frattari A, Esposito JE, et al. Monocyte distribution width (MDW) as a new tool for the prediction of sepsis in critically ill patients: a preliminary investigation in an intensive care unit. BMC Emerg Med. 2021;21(1):147. doi:10.1186/s12873-021-00521-4
   PubMed Web of Science ®Google Scholar
• Hall MW, Knatz NL, Vetterly C, et al. Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med. 2011;37(3):525–532. doi:10.1007/s00134-010-2088-x
   PubMed Web of Science ®Google Scholar
• Pachot A, Monneret G, Voirin N, et al. Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shock. Clin Immunol. 2005;114(1):61–69. doi:10.1016/j.clim.2004.08.015
   PubMed Web of Science ®Google Scholar
• Coudereau R, Waeckel L, Cour M, et al. Emergence of immunosuppressive LOX-1+ PMN-MDSC in septic shock and severe COVID-19 patients with acute respiratory distress syndrome. J Leukoc Biol. 2022;111(2):489–496. doi:10.1002/JLB.4COVBCR0321-129R
   PubMed Web of Science ®Google Scholar
• Feng T, Liao X, Yang X, et al. A shift toward inhibitory receptors and impaired effector functions on NK cells contribute to immunosuppression during sepsis. J Leukoc Biol. 2020;107(1):57–67. doi:10.1002/JLB.4A0818-313RR
   PubMed Web of Science ®Google Scholar
• Guo Y, Patil NK, Luan L, et al. The biology of natural killer cells during sepsis. Immunology. 2018;153(2):190–202. doi:10.1111/imm.12854
   PubMed Web of Science ®Google Scholar
• Poehlmann H, Schefold JC, Zuckermann-Becker H, et al. Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis. Crit Care. 2009;13(4):R119. doi:10.1186/cc7969
   PubMed Web of Science ®Google Scholar
• Guisset O, Dilhuydy M-S, Thiébaut R, et al. Decrease in circulating dendritic cells predicts fatal outcome in septic shock. Intensive Care Med. 2007;33(1):148–152. doi:10.1007/s00134-006-0436-7
   PubMed Web of Science ®Google Scholar
• Jimenez-Aguilar R, Sánchez-Zauco N, Tiburcio-Felix R, et al. Effects of cardiopulmonary bypass on the development of lymphopenia and sepsis after cardiac surgery in children with congenital cardiopathy. Exp Ther Med. 2020;19(1):435–442. doi:10.3892/etm.2019.8241
   PubMed Web of Science ®Google Scholar
• Wilson JK, Zhao Y, Singer M, et al. Lymphocyte subset expression and serum concentrations of PD-1/PD-L1 in sepsis - pilot study. Crit Care. 2018;22(1):95. doi:10.1186/s13054-018-2020-2
   PubMedGoogle Scholar
• Markwart R, Condotta SA, Requardt RP, et al. Immunosuppression after sepsis: systemic inflammation and sepsis induce a loss of naive T-cells but no enduring cell-autonomous defects in T-cell function. PLoS One. 2014;9(12):e115094. doi:10.1371/journal.pone.0115094
   PubMed Web of Science ®Google Scholar
• Huang LF, Yao Y-M, Dong N, et al. Association between regulatory T cell activity and sepsis and outcome of severely burned patients: a prospective, observational study. Crit Care. 2010;14(1):R3. doi:10.1186/cc8232
   PubMed Web of Science ®Google Scholar
• Skirecki T, Swacha P, Hoser G, et al. Bone marrow is the preferred site of memory CD4+ T cell proliferation during recovery from sepsis. JCI Insight. 2020;5(10). doi:10.1172/jci.insight.134475
   PubMed Web of Science ®Google Scholar
• Gupta DL, Bhoi S, Mohan T, et al. Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with post traumatic sepsis. Cytokine. 2016;88:214–221. doi:10.1016/j.cyto.2016.09.010
   PubMed Web of Science ®Google Scholar
• Hou YC, Pai M-H, Liu -J-J, et al. Alanyl-glutamine resolves lipopolysaccharide-induced lung injury in mice by modulating the polarization of regulatory T cells and T helper 17 cells. J Nutr Biochem. 2013;24(9):1555–1563. doi:10.1016/j.jnutbio.2013.01.004
   PubMed Web of Science ®Google Scholar
• Rauch PJ, Chudnovskiy A, Robbins CS, et al. Innate response activator B cells protect against microbial sepsis. Science. 2012;335(6068):597–601. doi:10.1126/science.1215173
   PubMed Web of Science ®Google Scholar
• Bermejo-Martin JF, Rodriguez-Fernandez A, Herrán-Monge R, et al. Immunoglobulins IgG1, IgM and IgA: a synergistic team influencing survival in sepsis. J Intern Med. 2014;276(4):404–412. doi:10.1111/joim.12265
   PubMed Web of Science ®Google Scholar
• Monserrat J, de Pablo R, Diaz-Martín D, et al. Early alterations of B cells in patients with septic shock. Crit Care. 2013;17(3):R105. doi:10.1186/cc12750
   PubMed Web of Science ®Google Scholar